Panel Discussion: Insight into Pharma’s Strategic Priorities & Data Wish List for Next Generation Engagers
Time: 11:45 am
day: Day One
Details:
- Which pharma are prioritizing engagers in immunology versus oncology, or moving in parallel into the clinic across both disease areas?
- What are the starting points, from a data package perspective, when it comes to assessing engagers?
- Uncovering key competitive differentiators prioritized in search and evaluation processes to drive deal-making and partnership decisions
